These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 11211924)

  • 1. L-arginine modifies free radical production and the development of experimental allergic encephalomyelitis.
    Scott GS; Bolton C
    Inflamm Res; 2000 Dec; 49(12):720-6. PubMed ID: 11211924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacological study on the role of nitric oxide in the pathogenesis of experimental allergic encephalomyelitis.
    Scott GS; Williams KI; Bolton C
    Inflamm Res; 1996 Oct; 45(10):524-9. PubMed ID: 8912019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease.
    O'Brien NC; Charlton B; Cowden WB; Willenborg DO
    J Immunol; 2001 Nov; 167(10):5904-12. PubMed ID: 11698467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction.
    O'Brien NC; Charlton B; Cowden WB; Willenborg DO
    J Immunol; 1999 Dec; 163(12):6841-7. PubMed ID: 10586085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors.
    Ruuls SR; Van Der Linden S; Sontrop K; Huitinga I; Dijkstra CD
    Clin Exp Immunol; 1996 Mar; 103(3):467-74. PubMed ID: 8608648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
    Gold DP; Schroder K; Powell HC; Kelly CJ
    Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
    Yin LL; Lin LL; Zhang L; Li L
    Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prazosin treatment during the effector stage of disease suppresses experimental autoimmune encephalomyelitis in the Lewis rat.
    Brosnan CF; Sacks HJ; Goldschmidt RC; Goldmuntz EA; Norton WT
    J Immunol; 1986 Dec; 137(11):3451-6. PubMed ID: 3491136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats.
    Núñez MJ; Balboa J; Rey-Méndez M; Brenlla J; González-Peteiro M; Rodrigo E; Freire-Garabal M
    Hum Exp Toxicol; 2007 Aug; 26(8):637-43. PubMed ID: 17884951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thalidomide and pentoxifylline on experimental autoimmune encephalomyelitis (EAE).
    Corrêa JO; Aarestrup BJ; Aarestrup FM
    Exp Neurol; 2010 Nov; 226(1):15-23. PubMed ID: 20406639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by CTLA4Ig of experimental allergic encephalomyelitis.
    Arima T; Rehman A; Hickey WF; Flye MW
    J Immunol; 1996 Jun; 156(12):4916-24. PubMed ID: 8648142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic response to experimental allergic encephalomyelitis: role of substance P.
    Ruocco HH; Fernandes GA; Namer IJ; Depaulis A; Levy S
    Neuroimmunomodulation; 2004; 11(1):28-35. PubMed ID: 14557676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis.
    Ljubisavljevic S; Stojanovic I; Pavlovic R; Sokolovic D; Pavlovic D; Cvetkovic T; Stevanovic I
    J Neurol Sci; 2012 Jul; 318(1-2):106-11. PubMed ID: 22507752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
    Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
    Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
    Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
    Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-arginine regulates neuronal nitric oxide synthase production of superoxide and hydrogen peroxide.
    Tsai P; Weaver J; Cao GL; Pou S; Roman LJ; Starkov AA; Rosen GM
    Biochem Pharmacol; 2005 Mar; 69(6):971-9. PubMed ID: 15748708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reduced glutathione and S-nitrosothiols levels in acute phase of experimental demyelination--pathophysiological approach and possible clinical relevancy.
    Ljubisavljevic S; Stojanovic I; Pavlovic R; Stojnev S; Stevanovic I; Sokolovic D; Pavlovic D
    Neuroscience; 2012 Sep; 219():175-82. PubMed ID: 22677204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of experimental autoimmune encephalomyelitis by Compound 48/80 in Lewis rats.
    Stanley NC; Jackson FL; Orr EL
    J Neuroimmunol; 1990; 29(1-3):223-8. PubMed ID: 2211986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
    Li XB; Schluesener HJ
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enkephalins and autoimmunity: differential effect of methionine-enkephalin on experimental allergic encephalomyelitis in Wistar and Lewis rats.
    Janković BD; Marić D
    J Neurosci Res; 1987; 18(1):88-94. PubMed ID: 3500326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.